This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1997 Jun 14;349(9067):1768; author reply 1769-70.

doi: 10.1016/S0140-6736(05)62983-2.

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials

R A Incalzi, A Gemma, P U Carbonin

PMID: 9193399
DOI: 10.1016/S0140-6736(05)62983-2

Comment

Amiodarone after myocardial infarction: EMIAT and CAMIAT trials

R A Incalzi et al. Lancet. 1997.

. 1997 Jun 14;349(9067):1768; author reply 1769-70.

doi: 10.1016/S0140-6736(05)62983-2.

Authors

R A Incalzi, A Gemma, P U Carbonin

PMID: 9193399
DOI: 10.1016/S0140-6736(05)62983-2

No abstract available

PubMed Disclaimer

Comment on

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Julian DG, et al. Lancet. 1997 Mar 8;349(9053):667-74. doi: 10.1016/s0140-6736(96)09145-3. Lancet. 1997. PMID: 9078197 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information